0001415889-21-003065.txt : 20210617
0001415889-21-003065.hdr.sgml : 20210617
20210617160510
ACCESSION NUMBER: 0001415889-21-003065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stanton Matthew
CENTRAL INDEX KEY: 0001814198
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39319
FILM NUMBER: 211024703
MAIL ADDRESS:
STREET 1: C/O GENERATION BIO CO.
STREET 2: 301 BINNEY STREET, SUITE 401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Generation Bio Co.
CENTRAL INDEX KEY: 0001733294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 814301281
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-529-5908
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4-06172021_010625.xml
X0306
4
2021-06-15
0001733294
Generation Bio Co.
GBIO
0001814198
Stanton Matthew
C/O GENERATION BIO CO., 301 BINNEY ST
CAMBRIDGE
MA
02142
false
true
false
false
CHIEF SCIENTIFIC OFFICER
Common Stock
2021-06-15
4
M
0
1500
4.59
A
199654
D
Common Stock
2021-06-15
4
S
0
1500
28.08
D
198154
D
Stock Option (right to buy)
4.59
2021-06-15
4
M
0
1500
0
D
2028-04-01
Common Stock
1500
99077
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The option to purchase 108,305 shares of common stock was granted on April 2, 2018. The shares underlying the option vest over four years, with 25% of the shares vested on April 2, 2019 and the remaining shares vesting in equal quarterly installments thereafter.
/s/ Jennifer Elliott, Attorney-in-Fact
2021-06-17